EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T cells leave the comfort zone: current and future applications beyond cancer

Mariana Torres Mazzi, Karina Lôbo Hajdu, Priscila Rafaela Ribeiro, Martín Hernán Bonamino iD

Immunotherapy Advances · 01.01.2021 · 1 (1)

DOI: 10.1093/immadv/ltaa006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 25.11.2020. Verfasst von Mariana Torres Mazzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian Ministry of Health, Brazilian National Council for Scientific and Technological Development, Rio de Janeiro Foundation for Research Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)-T cell therapy represents a breakthrough in the immunotherapy field and has achieved great success following its approval in 2017 for the treatment of B cell malignancies. While CAR-T cells are mostly applied as anti-tumor therapy in the present, their initial concept was aimed at a more general purpose of targeting membrane antigens, thus translating in many potential applications. Since then, several studies have assessed the use of CAR-T cells toward non-malignant pathologies such as autoimmune diseases, infectious diseases and, more recently, cardiac fibrosis, and cellular senescence. In this review, we present the main findings and implications of CAR-based therapies for non-malignant conditions.

Schlagwörter

Stichwörter der Autor:innen

CAR-T celladoptive cell transferautoimmune diseaseschimeric antigen receptorfibrosisinfectious diseases

Autor:innen und Institutionen

  • Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
  • Vice - Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

ORCID-Profile: Martín Hernán Bonamino

Förderung

  • Brazilian Ministry of Health
  • Brazilian National Council for Scientific and Technological Development
  • Rio de Janeiro Foundation for Research Support
  • Coordination of Superior Level Staff Improvement

Zitieren

APA

Mazzi, M. T., Hajdu, K. L., Ribeiro, P. R., & Bonamino, M. H. (2021). CAR-T cells leave the comfort zone: current and future applications beyond cancer. Immunotherapy Advances, 1(1). https://doi.org/10.1093/immadv/ltaa006

Vancouver

Mazzi MT, Hajdu KL, Ribeiro PR, Bonamino MH. CAR-T cells leave the comfort zone: current and future applications beyond cancer. Immunotherapy Advances. 2021;1(1). doi:10.1093/immadv/ltaa006

BibTeX
@article{Mazzi2021,
  author = {Mazzi, Mariana Torres and Hajdu, Karina Lôbo and Ribeiro, Priscila Rafaela and Bonamino, Martín Hernán},
  title = {CAR-T cells leave the comfort zone: current and future applications beyond cancer},
  journal = {Immunotherapy Advances},
  year = {2021},
  volume = {1},
  number = {1},
  doi = {10.1093/immadv/ltaa006}
}
Kostenlos starten →